DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
Home
Overview
Details
Browse by Letter:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0-9
Label and Approval History
Drug Name:
ZERIT
FDA Application No:
(NDA) 020412
Active Ingredient(s):
STAVUDINE
Company:
BRISTOL MYERS SQUIBB
Label History
View the
label approved on February 5, 2007
for ZERIT, (NDA) 020412
To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
Approval History
Action Date
Supplement Number
Approval Type
Letters, Reviews, Labels, Patient Package Insert
4/20/2007
027
Labeling Revision
Letter
Letter
6/6/2007
027
Labeling Revision
Letter
Letter
6/13/2007
027
Labeling Revision
Letter
Letter
6/21/2007
027
Labeling Revision
Letter
Letter
12/20/2005
024
Labeling Revision
Label
6/4/2004
023
Labeling Revision
Letter
Label
2/20/2002
018
Labeling Revision
Letter
2/20/2002
017
Labeling Revision
Letter
3/29/2002
016
Efficacy Supplement with Clinical Data to Support
Letter
Label
10/16/2001
015
Labeling Revision
Label
4/17/2001
014
Control Supplement
9/27/2000
013
Labeling Revision
6/10/1999
012
Manufacturing Change or Addition
9/16/1998
011
Labeling Revision
7/1/1999
010
New or Modified Indication
8/19/1998
009
Control Supplement
1/16/1998
008
Manufacturing Change or Addition
2/3/1998
007
Control Supplement
9/26/1997
006
Manufacturing Change or Addition
2/4/1998
005
Labeling Revision
9/6/1996
004
Patient Population Altered
2/9/1996
003
Control Supplement
12/21/1995
002
New or Modified Indication
8/2/1994
001
Control Supplement
6/24/1994
000
Approval
There are no Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test